Jeffrey G. Lamothe - Jan 29, 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: SVP and CFO
Signature: /s/ Carl A. Valenstein, attorney-in-fact
Stock symbol: APVO
Transactions as of: Jan 29, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/1/2022, 05:00 PM
Next filing: Mar 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+1.83K	+34.2%		7.19K	Jan 29, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	+1.83K	+99.95%	$0.00	3.67K	Jan 29, 2022	Common Stock	1.83K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022.